People | February 20, 2022
Resolution Therapeutics strengthens its team with two new appointments
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
Victor Dillard as VP Corporate Development and Lorna Peers as VP Finance
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
Last year, the company's early-stage breast cancer detection test became the first such test to receive the Breakthrough Device Designation
CliniSys has the proven ability to deliver 100s of millions of medical results a month to enable pandemic-scale population disease surveillance across the globe
Effectiveness of Covaxin against the Omicron variant is currently being studied
Lupin Diagnostics will provide a comprehensive range of diagnostic tests. These include molecular diagnostics, cytogenetics, flow cytometry, microbiology, serology, histopathology and cytology, haematology, immunology, amongst others.
It is the first blood test able to detect early-stage Breast Cancer with high accuracy in women above the age of 40 years
LSDCheck is CE-IVD approved LCMSMS-based testing kit for LSD in newborns
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
Takeda to exclusively commercialize JR-141 outside the U.S. (except Japan and certain other Asia-Pacific countries) upon regulatory approval
Subscribe To Our Newsletter & Stay Updated
